Exploring the Latest in MHT: Concerns Unveiled

Naari Division of Jagsonpal Pharma organized a webinar focused on Exploring the latest in Menopausal Hormone Therapy. The expert will help unveil all the concerns around MHT.

The topic expert, Dr. Meeta Singh Director & Consultant Obs Gyn & Menopause specialist at Tanvir Hospital Hyderabad.
Dr Meeta has held various prestigious posts at the Indian Menopause Society being National President IMS and Founder Hyderabad Menopause chapter. All doubts on MHT will be cleared by her talk as she is the Expert Chair of IMS Guidelines on Menopause & post-menopausal Osteoporosis Guidelines.
Her interest in research and academics can be seen as she holds the posts of Founder IMS Research Committee and currently Founder Chair IMS Registry for 10 years since 2021. We welcome and thank her for her commitment and support to midlife management.

Please participate in the Midlife Questionnaire Survey on Google Form: https://forms.gle/RXx1vSSCmKCSJ7Ud9
By participating in this survey, you will be contributing to National Midlife Population Awareness Survey under the banner of Tanvir Foundation. The survey has passed through the Ethics Committee. Your results will be kept confidential. We thank you in advance for your participation in the Midlife Survey.

NAARI division of Jagsonpal Pharma Ltd. presents for the first time in India, a USFDA-approved combination of bio-identical hormones for MHT, specifically to manage vasomotor symptoms in menopausal women, as a single daily capsule, MemUP, containing natural progesterone 100 mg with estradiol hemihydrate 1mg.

Contact with us on:
YouTube:    / @jagsonpalmedicalinsights2757  
Facebook:   / jagsonpalpharmaceuticals  
LinkedIn:   / jplmed  
Twitter: https://twitter.com/jagsonpalpharma?l...